2-(4-methyl-2-oxo-1-pyrrolidinyl) butyric acid
Brivaracetam 4-methyl butyric acid impurity is a fully characterized chemical compound used as a reference standard of API Brivaracetam. The standard offered is compliant with regulatory guidelines. Brivaracetam 4-methyl butyric acid impurity is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
